Condition

Advanced and Metastatic Silent Neuro-Endocrine Tumors (1)

Carcinoids (1)

Carcinoma (1)

Neuroendocrine (1)

Non Functioning (1)

Non Functioning Neuroendocrine Tumors (NETs) (1)

Non Syndromic Neuroendocrine Tumors (1)

Overall Status

Completed (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Novartis Pharmaceuticals (1)

Collaborator

Intervention

everolimus (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

non functioning neuroendocrine tumors (nets)

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Advanced and Metastatic Silent Neuro-Endocrine Tumors, Carcinoma, Neuroendocrine Trial in Worldwide (Everolimus)

Completed

Advanced and Metastatic Silent Neuro-Endocrine Tumors
+6 more

Everolimus

Bordeaux, France
+39 more

Aug 14, 2018